Finkelstein Thompson LLP Announces Investigation of Medco Health Solutions, Inc.

WASHINGTON--(BUSINESS WIRE)--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Medco Health Solutions, Inc. (“Medco” or the “Company”) (NYSE: MHS) concerning the proposed acquisition of the Company by Express Scripts. Under the terms of the offer, Medco shareholders will receive $28.80 in cash and 0.81 shares of Express Scripts for each share they own. Based on the Company’s closing price on Thursday, the transaction has an implied value of $71.36 per share. The total transaction value is approximately $29.1 billion.